Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
about
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesLong term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study.Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and Attenuates the Incidence and Severity of Collagen-induced Arthritis in MiceEffects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.On the potential of acarbose to reduce cardiovascular disease.A review of the efficacy and safety of oral antidiabetic drugsGhrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line.Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.Effective Control of Postprandial Glucose Level through Inhibition of Intestinal Alpha Glucosidase by Cymbopogon martinii (Roxb.).Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion.Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Incretin secretion in humans is under the influence of cannabinoid receptors.
P2860
Q26778095-FF239B1E-4DBD-4838-9B41-3A29E0EFFE4DQ34068305-8C733243-AC80-4FA8-AA7D-31264F5C9DC8Q34563587-B036C2D9-AB86-4476-BEEA-985C81D40158Q35047406-0421134E-1FD3-4840-AB43-F675FB8B4A27Q35772580-A4C0FFD9-A0C5-4113-8C1B-8A2D125265A5Q36382309-C4D274C6-C720-496D-8BCA-1A9DA14F6EEAQ36843439-22D399A8-A433-4E55-9D1D-80D6D7EC6A70Q37717838-71F67076-327C-4437-B9FE-5B9786B935EBQ38067491-F6CD1532-7822-4CC6-97D3-AB8701E3B2A0Q39047697-EE65FF5B-1AB9-4969-B642-E0B33BBB2AABQ40478728-29AE50E2-5FB2-4650-861E-63C7735D5F5FQ41845491-0AD48627-0151-4590-9ADB-C9CD102CCD06Q41972291-28F7E443-79BE-4BF3-A850-0D9F74867108Q43142618-E56EEC20-7E75-44AD-92B0-45F096F8C8EAQ45783993-4546B4ED-E0C7-41E0-BE58-9FECF9C01B29Q48215464-83D16DC0-0DD4-49B3-8E84-0444E5E86947
P2860
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@ast
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@en
type
label
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@ast
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@en
prefLabel
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@ast
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@en
P2093
P2860
P1476
Inhibition of gastric emptying ...... nd accompanied by CCK release.
@en
P2093
Bekiroğlu N
Rehfeld JF
P2860
P304
P356
10.1152/AJPGI.2001.281.3.G752
P577
2001-09-01T00:00:00Z